Alembic Pharmaceuticals Shareholding Pattern & Promoter Holding
Pharmaceuticals & Biotechnology · Latest pattern: Sep 2026
As of Sep 2026, promoters hold 69.87% of Alembic Pharmaceuticals, FIIs hold 4.55%, DIIs hold 15.44% and the public holds 10.16%. Promoter holding was unchanged from Jun 2026.
Get an alert when Alembic Pharmaceuticals reports results or its shareholding changes. Free account.
Promoters
69.87%
unchanged QoQ
FIIs
4.55%
+0.38 pp QoQ
DIIs
15.44%
−0.49 pp QoQ
Public
10.16%
+0.16 pp QoQ
Alembic Pharmaceuticals shareholding, quarter by quarter
| Quarter | Promoters | FIIs | DIIs | Public | Shareholders |
|---|---|---|---|---|---|
| Sep 2026 | 69.87% | 4.55% | 15.44% | 10.16% | 86,532 |
| Jun 2026 | 69.87% | 4.17% | 15.93% | 10.00% | 86,796 |
| Mar 2026 | 69.74% | 4.26% | 16.17% | 9.83% | 86,432 |
| Dec 2025 | 69.74% | 4.23% | 16.17% | 9.84% | 87,000 |
| Sep 2025 | 69.74% | 4.04% | 16.30% | 9.92% | 89,969 |
| Jun 2025 | 69.68% | 3.96% | 16.46% | 9.91% | 89,013 |
| Mar 2025 | 69.67% | 3.94% | 16.43% | 9.96% | 91,336 |
| Dec 2024 | 69.61% | 4.17% | 16.05% | 10.17% | 93,944 |
| Sep 2024 | 69.61% | 3.94% | 16.05% | 10.38% | 91,429 |
| Jun 2024 | 69.61% | 4.32% | 15.47% | 10.61% | 74,829 |
| Mar 2024 | 69.61% | 4.46% | 15.39% | 10.54% | 76,567 |
| Dec 2023 | 69.61% | 4.52% | 14.51% | 11.36% | 85,212 |
Promoters · FIIs (foreign institutions) · DIIs (domestic institutions) · Public (retail & others). Percentages of total shares, from the quarterly pattern filed with the exchanges.
Value of the promoter stake
At a market capitalisation of ₹20.25k cr, the promoter group's 69.87% stake is worth ₹14.15k cr. A promoter group is usually a family, trust or holding company; this figure covers only this listed company and is not anyone's net worth.
Promoter holding in Pharmaceuticals & Biotechnology peers
Alembic Pharmaceuticals shareholding: common questions
What is the promoter holding in Alembic Pharmaceuticals?
Promoters hold 69.87% of Alembic Pharmaceuticals as of Sep 2026. Their stake was unchanged from Jun 2026.
How much do FIIs hold in Alembic Pharmaceuticals?
Foreign institutional investors (FIIs) held 4.55% of Alembic Pharmaceuticals in Sep 2026, +0.38 pp versus Jun 2026.
How much do mutual funds and other DIIs hold in Alembic Pharmaceuticals?
Domestic institutional investors (DIIs), which include mutual funds and insurers, held 15.44% of Alembic Pharmaceuticals in Sep 2026, −0.49 pp versus Jun 2026.
Is the promoter holding in Alembic Pharmaceuticals pledged?
The latest disclosed shareholding pattern shows no pledged promoter shares in Alembic Pharmaceuticals.
How has Alembic Pharmaceuticals's promoter holding changed in the last year?
Promoter holding moved from 69.74% in Sep 2025 to 69.87% in Sep 2026 (+0.13 pp).
How many shareholders does Alembic Pharmaceuticals have?
Alembic Pharmaceuticals had 86,532 shareholders in Sep 2026, compared with 86,796 in Jun 2026.